Rethinking Off-Label Regulation in the Wake of Sorrell v. IMS Health: Can State Involvement Compensate for Waning FDA Authority to Curb Commercial Free Speech?

Authors

Ashley A. Zborowsky

Document Type

Note & Comment

Recommended Citation

Ashley A. Zborowsky, Rethinking Off-Label Regulation in the Wake of Sorrell v. IMS Health: Can State Involvement Compensate for Waning FDA Authority to Curb Commercial Free Speech?, 13 Minn. J.L. Sci. & Tech. 925 (2012).
Available at: https://scholarship.law.umn.edu/mjlst/vol13/iss2/17